Cellcyte Genetics Corp.: key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2013)
- -$164.0K
- Total Assets (FY2013)
- $9.0K
- Total Equity (FY2013)
- -$819.8K
- Cash Flows from Operating Activities (FY2013)
- -$62.7K
Source: Cellcyte Genetics Corp. 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
